Mipeginterferon ALFA-2B clinical trials
How each study uses mipeginterferon ALFA-2B is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ypeginterferon alfa-2b
- 4
Studies by the year they started
4 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses mipeginterferon ALFA-2B is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT01760122Written as Ypeginterferon alfa-2bHow we know
- Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C PatientsCompletedPhase 3Xiamen Amoytop Biotech Co., Ltd.NCT01581398Written as Ypeginterferon alfa-2bHow we know
- Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedPhase 2Xiamen Amoytop Biotech Co., Ltd.NCT01143662Written as Ypeginterferon alfa-2bHow we know
- Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis CCompletedPhase 2Xiamen Amoytop Biotech Co., Ltd.NCT01140997Written as Ypeginterferon alfa-2bHow we know
Given beside what is tested · 1 — mipeginterferon ALFA-2B is usual care or a partner of the new treatment
Codes
What other systems call mipeginterferon ALFA-2B · ClinicalTrials.gg INT035254
- UNII (FDA) 3T2DJE639QMIPEGINTERFERON ALFA-2BOne source FDA
- NCI Thesaurus C166693Mipeginterferon Alfa-2BOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 3T2DJE639Q | MIPEGINTERFERON ALFA-2B | One source FDA |
| NCI Thesaurus | C166693 | Mipeginterferon Alfa-2B | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.